Buchumschlag

Intracranial hypertension with papilledema associated with long‐term use of over‐the‐counter retinol day cream

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Matthieu Batens, Liesbeth Huys, Sven Dekeyzer, Nicolas Vandenbussche, Elke O. Kreps
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Headache: The Journal of Head and Face Pain
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Arachnoid granulations in idiopathic intracranial hypertension: Do they have an influence?
von: Arndt‐Hendrik Schievelkamp, et al.
Veröffentlicht: (2024)

Evaluating associations of migraine‐related vertigo
von: Nazia Karsan, et al.
Veröffentlicht: (2025)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
von: Graham A. McLeod, et al.
Veröffentlicht: (2025)

Clinical factors associated with day‐to‐day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary data
von: Marina Vives‐Mestres, et al.
Veröffentlicht: (2024)

Baseline factors associated with post‐stenting intracranial pressure in patients with idiopathic intracranial hypertension with venous sinus stenosis
von: Shuang Song, et al.
Veröffentlicht: (2025)

A randomized sequential cross‐over trial evaluating five purportedly ICP ‐lowering drugs in idiopathic intracranial hypertension
von: James L. Mitchell, et al.
Veröffentlicht: (2025)

In reply to: “Glymphatic dysfunction is unlikely to cause idiopathic intracranial hypertension”
von: Derrek Schartz, et al.
Veröffentlicht: (2026)

Migraine, idiopathic intracranial hypertension, and calcitonin gene‐related peptide antibodies
von: Irina Krikova, et al.
Veröffentlicht: (2024)

Deep brain stimulation for chronic refractory cluster headache: A case series about long‐term outcomes and connectivity analysis
von: Juan Ángel Aibar‐Durán, et al.
Veröffentlicht: (2024)

A unifying disease model of idiopathic intracranial hypertension: A narrative review
von: Derrek Schartz, et al.
Veröffentlicht: (2025)

Cerebrospinal fluid and serum biomarkers in idiopathic intracranial hypertension: A systematic review
von: Marina Romozzi, et al.
Veröffentlicht: (2025)

Role of diffusion tensor imaging in the evaluation of white matter integrity in idiopathic intracranial hypertension
von: Bahar Atasoy, et al.
Veröffentlicht: (2024)

The pathogenic role of calcitonin gene‐related peptide and predictors of new‐onset migraine and long‐term outcomes after transcatheter atrial septal defect closure
von: Tzu‐Hsuan Su, et al.
Veröffentlicht: (2024)

Arterial hypertension: A safety risk of calcitonin gene‐related peptide ligand and receptor blocker class
von: David Croteau, et al.
Veröffentlicht: (2026)

Is headache always necessary for the diagnosis of rebound intracranial hypertension in patients successfully treated for cerebrospinal fluid venous fistula?
von: Rayyan Kinsara, et al.
Veröffentlicht: (2026)

Assessing blood pressure changes and hypertension‐related outcomes in patients with migraine treated with erenumab: A systematic review and meta‐analysis
von: Luana Miyahira Makita, et al.
Veröffentlicht: (2025)

Impact of Ramadan fasting on vision and headache‐related quality of life in women with idiopathic intracranial hypertension: A prospective observational study
von: Mona Hussein, et al.
Veröffentlicht: (2024)

A multicenter, prospective, single‐arm study of 60‐day peripheral nerve stimulation of the occipital nerves for the treatment of headache
von: Genaro G. Gutierrez, et al.
Veröffentlicht: (2025)

Long‐term evolution of white and gray matter structural properties in migraine
von: Álvaro Planchuelo‐Gómez, et al.
Veröffentlicht: (2025)

Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache
von: Andrew Blumenfeld, et al.
Veröffentlicht: (2024)

Depression and anxiety are not associated with migraine outcomes in children and adolescents
von: Amy A. Gelfand
Veröffentlicht: (2024)

Headache activity associated with the 2024 North American eclipse
von: Timothy T. Houle, et al.
Veröffentlicht: (2024)

What a long strange trip it's been: Reflections on serial snapshots of migraine prevalence and burden in the United States
von: Fred Cohen, et al.
Veröffentlicht: (2025)

Causal associations between genetically predicted placental weight and migraine
von: Chung‐Chih Liao, et al.
Veröffentlicht: (2025)

Time to reconsider the association between migraine and white matter hyperintensities?
von: Anders Hougaard
Veröffentlicht: (2025)

Long‐term air pollution exposure and incident migraine in middle aged and older adults: A population‐based study
von: Panpan Zhang, et al.
Veröffentlicht: (2026)

The association between posttraumatic stress disorder and migraine: A systematic review
von: Lucie Nitsche, et al.
Veröffentlicht: (2026)

Waning light, waxing pain: The lunar cycle's association with migraine headache occurrence
von: Alexander Yoo, et al.
Veröffentlicht: (2025)

Factors associated with efficacy of occipital nerve stimulation in medically intractable chronic cluster headache
von: Roemer B. Brandt, et al.
Veröffentlicht: (2025)

Neuralgia in the occipital region associated with ipsilateral trigeminal herpes zoster: Three case reports
von: Akihiko Nakaya, et al.
Veröffentlicht: (2024)

Plain Language Summary Publication: Hyperactivity of the medial thalamus in patients with photophobia‐associated migraine
von: Yukihisa Suzuki, et al.
Veröffentlicht: (2024)

Epidemiology of primary headache associated with sexual activity: A meta‐analysis with diagnostic and management considerations
von: Aleksander Osiowski, et al.
Veröffentlicht: (2025)

Cluster Analysis of Migraine‐associated Symptoms (CAMS) in youth: A retrospective cross‐sectional multicenter study
von: Carlyn Patterson Gentile, et al.
Veröffentlicht: (2024)

Long‐term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trial
von: Anna Gryglas‐Dworak, et al.
Veröffentlicht: (2024)

Efficacy of galcanezumab in proline‐rich transmembrane protein 2 ( PRRT2 ) ‐associated familial hemiplegic migraine: A case series
von: Costanza Sottani, et al.
Veröffentlicht: (2024)

A history of abuse is associated with more severe migraine‐ and pain‐related disability: Results from the American Registry for Migraine Research
von: Meesha Trivedi, et al.
Veröffentlicht: (2024)

No association between migraine and HLA alleles in a cohort of 13,210 individuals with migraine from the Danish Blood Donor Study
von: Inga Zalia Tummoszeit, et al.
Veröffentlicht: (2024)

Prevalence and factors associated with primary headache disorders among Emirati population in Dubai, United Arab Emirates: A cross‐sectional study
von: Shaista Anwar Siddiqi, et al.
Veröffentlicht: (2026)

Swiss Quality of Life and Health Care Impact Assessment in a Real‐World Erenumab‐Treated Migraine Population: Results over 2 years
von: Andreas R. Gantenbein, et al.
Veröffentlicht: (2025)

A 3‐year follow‐up study of outcomes associated with patterns of traditional acute and preventive migraine treatment: An administrative claims‐based cohort study in the United States
von: Shivang Joshi, et al.
Veröffentlicht: (2024)